These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32864693)

  • 1. Long-term systemic glucocorticoid therapy and weight gain: a population-based cohort study.
    Fardet L; Nazareth I; Petersen I
    Rheumatology (Oxford); 2021 Mar; 60(3):1502-1511. PubMed ID: 32864693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study.
    Fardet L; Petersen I; Nazareth I
    PLoS Med; 2016 May; 13(5):e1002024. PubMed ID: 27218256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study.
    Horton DB; Haynes K; Denburg MR; Thacker MM; Rose CD; Putt ME; Leonard MB; Strom BL
    BMJ Open; 2017 Jul; 7(7):e016788. PubMed ID: 28733303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Glucocorticoids and Early Variations of Blood Pressure: A Population-Based Cohort Study.
    Fardet L; Nazareth I; Petersen I
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2777-83. PubMed ID: 25978108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic glucocorticoid therapy: risk factors for reported adverse events and beliefs about the drug. A cross-sectional online survey of 820 patients.
    Morin C; Fardet L
    Clin Rheumatol; 2015 Dec; 34(12):2119-26. PubMed ID: 25956956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study.
    Fardet L; Petersen I; Nazareth I
    Medicine (Baltimore); 2015 Apr; 94(15):e647. PubMed ID: 25881838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study.
    Stuijver DJF; Majoor CJ; van Zaane B; Souverein PC; de Boer A; Dekkers OM; Büller HR; Gerdes VEA
    Chest; 2013 May; 143(5):1337-1342. PubMed ID: 23258429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study.
    Reynolds RM; Labad J; Sears AV; Williamson RM; Strachan MW; Deary IJ; Lowe GD; Price JF; Walker BR;
    Eur J Endocrinol; 2012 May; 166(5):861-8. PubMed ID: 22408122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases.
    Tatsuno I; Sugiyama T; Suzuki S; Yoshida T; Tanaka T; Sueishi M; Saito Y
    J Clin Endocrinol Metab; 2009 May; 94(5):1671-7. PubMed ID: 19258412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
    Majumdar SR; Lix LM; Yogendran M; Morin SN; Metge CJ; Leslie WD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1236-42. PubMed ID: 22298803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.
    Yood RA; Harrold LR; Fish L; Cernieux J; Emani S; Conboy E; Gurwitz JH
    Arch Intern Med; 2001 May; 161(10):1322-7. PubMed ID: 11371261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid use, other associated factors, and the risk of tuberculosis.
    Jick SS; Lieberman ES; Rahman MU; Choi HK
    Arthritis Rheum; 2006 Feb; 55(1):19-26. PubMed ID: 16463407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.
    Daugherty J; Lin X; Baxter R; Suruki R; Bradford E
    J Asthma; 2018 Jun; 55(6):651-658. PubMed ID: 28925768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: A retrospective cohort study.
    Wallace BI; Lin P; Kamdar N; Noureldin M; Hayward R; Fox DA; Curtis JR; Saag KG; Waljee AK
    Semin Arthritis Rheum; 2020 Apr; 50(2):228-236. PubMed ID: 31522762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Glucocorticoids and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
    Smit J; Kaasch AJ; Søgaard M; Thomsen RW; Nielsen H; Frøslev T; Schønheyder HC
    Mayo Clin Proc; 2016 Jul; 91(7):873-80. PubMed ID: 27289410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index.
    Zhang YP; Gong Y; Zeng QY; Hou ZD; Xiao ZY
    BMJ Open; 2015 Jun; 5(6):e006957. PubMed ID: 26041488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.
    George MD; Baker JF; Winthrop K; Hsu JY; Wu Q; Chen L; Xie F; Yun H; Curtis JR
    Ann Intern Med; 2020 Dec; 173(11):870-878. PubMed ID: 32956604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe neuropsychiatric outcomes following discontinuation of long-term glucocorticoid therapy: a cohort study.
    Fardet L; Nazareth I; Whitaker HJ; Petersen I
    J Clin Psychiatry; 2013 Apr; 74(4):e281-6. PubMed ID: 23656853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are adverse events higher among patients with acute optic neuritis prescribed glucocorticoids? A retrospective, longitudinal cohort study.
    De Lott LB; Brennan B; Wallace B; Kerber K; Burke JF; Roslin C; Terman S; Andrews C; Waljee AK; Banerjee M
    BMJ Open; 2024 Jul; 14(7):e076801. PubMed ID: 38991687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
    Wong BL; Rybalsky I; Shellenbarger KC; Tian C; McMahon MA; Rutter MM; Sawnani H; Jefferies JL
    J Pediatr; 2017 Mar; 182():296-303.e1. PubMed ID: 28043681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.